small sized icon representing the Cardiovascular area of interest
Cardiorenal
small sized icon representing the Hematology area of interest
Hematología
small sized icon representing the Ophthalmology area of interest
Oftalmología
small sized icon representing the Oncology area of interest
Oncología
small sized icon representing the Women's Health area of interest
Salud de la Mujer
SPACETu portal médico
Darolutamide + ADT + Docetaxel in mHSPC by Subgroups
Ir al contenido
Oncología

Darolutamide + ADT + Docetaxel in mHSPC by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial

Maha Hussain, et al. J Clin Oncol. 2023 Jul 10;41(20):3595-3507.

Related Contents
Informe SEOM de evaluación de darolutamida en CPRCnm
CPRCnm
Treatment of nmCRPC: comorbidities and DDIs
CPRCnm